Thanks, Ken! It seems to me CYDY knew all these findings in May. Just a question to the board: why didn't CYDY resubmit/reapply the Breakthrough Therapy Designation (BTD) again? If it did, we'd know something from the FDA long before now since the FDA typically aims to respond to BTD applications within 60 days.